Key result
MCS plus sequential immunosuppression improves LVEF from ~23% to 63% in giant cell myocarditis.
Case Report (n=1)
No
Giant cell myocarditis can present with a pseudo-amyloid apical sparing echocardiographic pattern due to basal/mid-ventricular oedema, and stepwise escalation from steroid monotherapy to combination immunosuppression with cyclosporine is a viable strategy to manage infection risk in patients requiring mechanical circulatory support.
Answers are grounded in this paper and cite their sources.
Supports stepwise immunosuppression in fulminant giant cell myocarditis on MCS; hypothesis-generating and requires prospective validation.
Background: Giant cell myocarditis typically has a poor prognosis among the various types of myocarditis. Early diagnosis and treatment are essential to save lives. Immunosuppressive therapy is used for giant cell myocarditis; however, evidence in patients on mechanical circulatory support is insufficient. Case summary: , and rapid myocardial histology indicated inflammatory cell infiltration. She was later diagnosed with giant cell myocarditis with cellular infiltration of irregular multinucleated giant cells in the myocardium. Her condition improved after starting mechanical circulatory support and sequential immunosuppressive therapy, and after successful rehabilitation, she was discharged as an outpatient on Day 183. Discussion: Early diagnosis and prompt initiation of immunosuppressive therapy are essential in giant cell myocarditis; however, specific findings are lacking. Early myocardial biopsy and prompt mechanical circulatory support initiation should be performed in patients with rapidly deteriorating heart failure presenting with amyloidosis-like echocardiographic findings and in cases where only troponin is elevated and creatine phosphokinase MB is not, considering the possibility of severe oedema. Combination immunosuppressive therapy under mechanical circulatory support is associated with a high infection risk, and starting with single-drug immunosuppressive therapy with careful haemodynamic monitoring is acceptable.
No takes yet. Share an insight, caveat, or question.
Sawada et al. (2026) conducted a case report in Fulminant giant cell myocarditis mimicking cardiac amyloidosis (n=1). Mechanical circulatory support (ECPELLA: V-A ECMO and Impella CP/5.0) and sequential immunosuppressive therapy (methylprednisolone, prednisolone, and cyclosporine) was evaluated on Clinical recovery, LVEF improvement, and histological resolution of giant cell myocarditis. Mechanical circulatory support and sequential steroid-to-cyclosporine therapy improved LVEF from 22.6% to 63% and enabled hospital discharge on Day 183 in a patient with giant cell myocarditis.
Synapse has enriched 10 related papers. Consider them for comparative context: